Lymphoma News

In this video, Matthew Matasar, MD, chief of the division of blood disorders at Rutgers Cancer Institute, discusses treatment disparities that exist for patients with DLBCL.

In this video, Matthew Matasar, MD, chief of the division of blood disorders at Rutgers Cancer Institute, discusses the current treatment landscape for DLBCL.

In this video, Matthew Matasar, MD, chief of the division of blood disorders at Rutgers Cancer Institute, discusses highlights in non-Hodgkin lymphoma from ASCO 2023.

In this video, Matthew Matasar, MD, chief of the division of blood disorders at Rutgers Cancer Institute, discusses the latest research on DLBCL presented at ASCO 2023.

In this video, Michael Choi, MD, discusses updated data on the results of pirtobrutinib treatments on mantle lymphocytic leukemia, presented at ASCO Annual Meeting.

Nearly 7,000 abstracts had been submitted for presentation at this year’s ASCO Annual Meeting.

In this video, Jing-Zhou Hou, MD, PhD, medical oncologist and hematologist, clinical instructor and co-chair of the hematological malignancies program at UPMC Hillman Cancer Center, discussed alternative therapies for lymphoma.

In this video, Jing-Zhou Hou, MD, PhD, medical oncologist and hematologist, clinical instructor and co-chair of the hematological malignancies program at UPMC Hillman Cancer Center, discussed using circulating tumor DNA to guide lymphoma therapy.

In this video, Jing-Zhou Hou, MD, PhD, medical oncologist and hematologist, clinical instructor and co-chair of the hematological malignancies program at UPMC Hillman Cancer Center, discussed therapeutic options for hard to treat lymphoma.

In this video, Jing-Zhou Hou, MD, PhD, medical oncologist and hematologist, clinical instructor and co-chair of the hematological malignancies program at UPMC Hillman Cancer Center, discussed advancements in molecular targets in lymphoma.